The drug is a fusion protein comprising the human interleukin (IL)-1 type 1 receptor ... drugs including Kinaret (anakinra), an IL-1 receptor antagonist approved to treat rheumatoid arthritis ...

The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.

Elevation of the proinflammatory cytokine Interleukin-1 (IL-1) is an integral part of the local tissue reaction to central nervous system (CNS) insult. The discovery of increased IL-1 levels in ...

The drug is a fusion protein comprising the human interleukin (IL)-1 type 1 receptor ... drugs including Kinaret (anakinra), an IL-1 receptor antagonist approved to treat rheumatoid arthritis ...